From: Anatomic mapping of molecular subtypes in diffuse glioma
Characteristic | Total number | Sex | Age | |||
---|---|---|---|---|---|---|
143 | Male | Female | 0–35 | 36–60 | >60 | |
Molecular subtype | ||||||
Triple-positive | 41 (29%) | 23 | 18 | 9 | 32 | 0 |
TERT and IDH mutation | 7 (5%) | 3 | 4 | 4 | 3 | 0 |
IDH mutation only | 37 (26%) | 25 | 12 | 19 | 18 | 0 |
Triple-negative | 27 (19%) | 14 | 13 | 7 | 17 | 3 |
TERT mutation only | 30 (21%) | 21 | 9 | 5 | 13 | 12 |
Other | 1 (1%) | 1 | 0 | 1 | 0 | 0 |
WHO grade | ||||||
Grade II | 82 (57%) | 45 | 37 | 34 | 45 | 3 |
Grade III | 27 (19%) | 17 | 10 | 6 | 21 | 0 |
Grade IV | 34 (24%) | 25 | 9 | 5 | 17 | 12 |
Pathological Diagnosis | ||||||
Astrocytoma | 69 (48%) | 43 | 26 | 29 | 37 | 3 |
Oligodendroglioma | 40 (28%) | 19 | 21 | 11 | 29 | 0 |
Glioblastoma | 34 (24%) | 25 | 9 | 5 | 17 | 12 |